Clyde Biosciences

Clyde Launches New Contractility Service – CellOPTIQ®-X

Posted on Leave a commentPosted in news

NEWHOUSE – Clyde Biosciences today announced the launch of a new service to serve the needs of its global pharma clients. CellOPTIQ®-X represents a revolution in contractility assays, offering: Early detection of contractility toxicities Higher throughput, cost-effective solution Reduction in animal requirements Accurate prediction of the human response Reduction in later stage attrition Heart cell […]